We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more
- Completed two equity offerings with total gross proceeds of approximately $20.0 million; cash runway extended into 3Q 2025 - - Announced new preclinical pharmacokinetic data supporting...
SAN JOSE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (βRani Therapeuticsβ or βRaniβ) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
-Transenteric delivery of incretin triagonist GLP-1, GIP, glucagon receptors mimicking the RaniPill route of administration elicits rapid weight loss and bioavailability comparable to subcutaneous...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3415 | -19.3879868287 | 1.7614 | 1.7614 | 1.3 | 793795 | 1.46537615 | CS |
4 | -0.6601 | -31.7355769231 | 2.08 | 2.16 | 1.3 | 553164 | 1.76520026 | CS |
12 | -0.7001 | -33.0235849057 | 2.12 | 3.75 | 1.3 | 1973800 | 2.68020252 | CS |
26 | -2.4801 | -63.5923076923 | 3.9 | 4.37 | 1.3 | 939773 | 2.69118906 | CS |
52 | -1.7001 | -54.4903846154 | 3.12 | 8.75 | 1.3 | 533263 | 2.94137895 | CS |
156 | -16.3601 | -92.0140607424 | 17.78 | 27.13 | 1.3 | 214582 | 3.73255529 | CS |
260 | -9.8401 | -87.3898756661 | 11.26 | 36.27 | 1.3 | 213707 | 5.54030954 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions